Interesting, thanks. Though not having read her book, one of the critiques seem to be that pharma companies spent a disproportionate amount on marketing and sal

Interesting, thanks. Though not having read her book, one of the critiques seem to be that pharma companies spent a disproportionate amount on marketing and sales. And that is something I have to agree with. At the moment it looks like the industry is closing research facilities all the time one of their drugs falls from the patent cliff while keeping marketing budgets untouched. Looking at the research organization and the innovation of their approaches, I must say that they are vastly behind and extremely conservative. Novartis seems to be doing it right, though.